GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EBR Systems Inc (OTCPK:EBRCZ) » Definitions » Institutional Ownership

EBRCZ (EBR Systems) Institutional Ownership : 3.94% (As of Sep. 21, 2024)


View and export this data going back to 2022. Start your Free Trial

What is EBR Systems Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, EBR Systems's institutional ownership is 3.94%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, EBR Systems's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, EBR Systems's Float Percentage Of Total Shares Outstanding is 0.00%.


EBR Systems Institutional Ownership Historical Data

The historical data trend for EBR Systems's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EBR Systems Institutional Ownership Chart

EBR Systems Historical Data

The historical data trend for EBR Systems can be seen below:

2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31
Institutional Ownership 3.81 3.83 3.91 3.97 3.95 3.96 4.05 4.05 4.05 4.04

EBR Systems Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


EBR Systems Business Description

Traded in Other Exchanges
Address
480 Oakmead Parkway, Sunnyvale, CA, USA, 94085
EBR Systems Inc is engaged in treatment for patients suffering from cardiac rhythm diseases by developing therapies using wireless cardiac stimulation. The company's Wise CRT System uses proprietary wireless technology to deliver pacing stimulation directly inside of the left ventricle of the heart.